Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-la... by Marabelle, Aurélien, MD, Fakih, Marwan, MD, Lopez, Juanita, MB BChir, Shah, Manisha, MD, Shapira-Frommer, Ronnie, MD, Nakagawa, Kazuhiko, MD, Chung, Hyun Cheol, MD, Kindler, Hedy L, MD, Lopez-Martin, Jose A, MD, Miller, Wilson H, MD, Italiano, Antoine, MD, Kao, Steven, MD, Piha-Paul, Sarina A, MD, Delord, Jean-Pierre, MD, McWilliams, Robert R, Prof, Fabrizio, David A, PhD, Aurora-Garg, Deepti, PhD, Xu, Lei, PhD, Jin, Fan, MD, Norwood, Kevin, MD, Bang, Yung-Jue, MD

Get full text

Does Health-Related Quality of Life Improve for Advanced Pancreatic Cancer Patients Who Respond to Gemcitabine? Analysis of a Randomized Phase III Trial of the Cancer and Leukemia... by Romanus, Dorothy, MSc, Kindler, Hedy L., MD, Archer, Laura, MSc, Basch, Ethan, MD, Niedzwiecki, Donna, PhD, Weeks, Jane, MD, Schrag, Deborah, MD

Get full text

Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase... by Maio, Michele, Prof, Scherpereel, Arnaud, Prof, Calabrò, Luana, MD, Aerts, Joachim, MD, Perez, Susana Cedres, PhMd, Bearz, Alessandra, MD, Nackaerts, Kristiaan, MD, Fennell, Dean A, Prof, Kowalski, Dariusz, MD, Tsao, Anne S, Prof, Taylor, Paul, MBChB, Grosso, Federica, MD, Antonia, Scott J, Prof, Nowak, Anna K, Prof, Taboada, Maria, MSc, Puglisi, Martina, MD, Stockman, Paul K, MBChB, Kindler, Hedy L, Prof

Get full text

Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study by Kindler, Hedy L, Dr, Ioka, Tatsuya, MD, Richel, Dirk J, MD, Bennouna, Jaafar, MD, Létourneau, Richard, MD, Okusaka, Takuji, MD, Funakoshi, Akihiro, MD, Furuse, Junji, MD, Park, Young Suk, MD, Ohkawa, Shinichi, MD, Springett, Gregory M, MD, Wasan, Harpreet S, MB, Trask, Peter C, PhD, Bycott, Paul, PhD, Ricart, Alejandro D, MD, Kim, Sinil, MD, Van Cutsem, Eric, MD

Get full text

Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-control... by Krug, Lee M, Dr, Kindler, Hedy L, Prof, Calvert, Hilary, MD, Manegold, Christian, Prof, Tsao, Anne S, MD, Fennell, Dean, Prof, Öhman, Ronny, MD, Plummer, Ruth, Prof, Eberhardt, Wilfried E E, MD, Fukuoka, Kazuya, MD, Gaafar, Rabab M, Prof, Lafitte, Jean-Jacques, Prof, Hillerdal, Gunnar, MD, Chu, Quincy, MD, Buikhuisen, Wieneke A, MD, Lubiniecki, Gregory M, MD, Sun, Xing, PhD, Smith, Margaret, BA, Baas, Paul, Prof

Get full text

Anetumab ravtansine versus vinorelbine in patients with relapsed, mesothelin-positive malignant pleural mesothelioma (ARCS-M): a randomised, open-label phase 2 trial by Kindler, Hedy L, Prof, Novello, Silvia, Prof, Bearz, Alessandra, MD, Ceresoli, Giovanni L, MD, Aerts, Joachim G J V, Prof, Spicer, James, Prof, Taylor, Paul, MB ChB, Nackaerts, Kristiaan, Prof, Greystoke, Alastair, MBChB, Jennens, Ross, MBBS, Calabrò, Luana, MD, Burgers, Jacobus A, MD, Santoro, Armando, Prof, Cedrés, Susana, MD, Serwatowski, Piotr, MD, Ponce, Santiago, MD, Van Meerbeeck, Jan P, Prof, Nowak, Anna K, Prof, Blumenschein, George, Prof, Siegel, Jonathan M, MS, Kasten, Linda, MA, Köchert, Karl, PhD, Walter, Annette O, PhD, Childs, Barrett H, MD, Elbi, Cem, MD, Hassan, Raffit, MD, Fennell, Dean A, Prof

Get full text